Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 12/30/13  and contains information from public web pages.

Prof. Sandra V. Navarra

Wrong Prof. Sandra V. Navarra?

Professor

Company Description: The Lupus Academy is a long-term initiative committed to improving patient outcomes in SLE and allied diseases. By providing a highly interactive educational forum,...   more
Background

Employment History

Board Memberships and Affiliations

  • Member of the Steering Committee
    Lupus Academy
  • Founder
    Arthritis Care and Research Foundation of the Philippines

Education

  • MD
  • M.D.
60 Total References
Web References
Steering Committee
www.lupus-academy.org, 30 Dec 2013 [cached]
Professor Sandra V. Navarra, MD, FPCP, FPRA
University of Santo Tomas, Manila
...
Sandra Navarra is Professor and Head of Rheumatology at University of Santo Tomas, and consultant Rheumatologist at St. Luke's Medical Center in the Philippines. She served as Secretary-General, Head of the Education Committee, chaired the special interest group on systemic lupus erythematosus (SLE) of the Asia Pacific League of Associations for Rheumatology (APLAR) and was a former President of the Philippine Rheumatology Association. She founded the Arthritis Care and Research Foundation of the Philippines where she is currently the Scientific Programmes Director, and the Lupus Foundation of the Philippines where she served as Medical Director. Currently President and CEO of the Rheumatology Educational Trust Foundation Inc. (RETFI), she is the prime mover of Lupus Inspired Advocacy (LUISA) Project for lupus education and research, and the People Empowerment for Arthritis and Lupus (PE ARL) Movement for lay education and medical assistance programmes.
Professor Navarra was Senior Associate Editor of the International Journal of Rheumatic Diseases, is an experienced clinical trials investigator and has published widely in the field of lupus and other rheumatic diseases. She is a well-known lecturer in a broad range of topics in rheumatology and has received several university and national awards for education and research.
Professor Navarra has organised several national and regional educational meetings including the Ten Topics in Rheumatology (Asia, 2009) and chaired the organising committee for the Asian Lupus Summit held in Manila, Philippines in November 2012.
Disclosures Grant/Research: GlaxoSmithKline, Human Genome Sciences Consultant/Advisor:GlaxoSmithKline, Human Genome Sciences Speakers' Bureau: GlaxoSmithKline, Human Genome Sciences, Pfizer, Roche Professor Navarra is a member of the Lupus Academy Steering Committee and has been involved in the planning and development of the inaugural meeting programme and materials.
retfi.org
www.retfi.org, 14 Mar 2011 [cached]
Further details of the various activities of the LUISA Project may be viewed at www.luisaproject.org . The trophy was received onstage by Dr. Sandra Navarra (Section chief of Rheumatology) and Ms. Ma.
...
It was a double celebration for UST Rheumatology, as Section chief Dr. Sandra V. Navarra also received the Gawad Benavides Medal for her selfless dedication as teacher in Rheumatology of the UST Faculty of Medicine and Surgery in the past twenty five years.
...
Rheumatologists rejoice in the US FDA approval of the first new drug for lupus in 56 years: Belimumab (BENLYSTA) . Prof. Sandra V. Navarra,MD is lead author of a recent publication at The Lancet on one of the two phase 3 trials on belimumab. Dr. Navarra is the Head of Rheumatology at the University of Santo Tomas in Manila, Philippines.
CHRISTMAS “Rheum†for Kids and Teens
www.retfi.org, 11 Dec 2010 [cached]
Dr. Sandra Navarra, Section Chief of Rheumatology and president of Rheumatology Educational Trust Foundation presented the current data on SLE underscoring the "young age of predilection" and relatively high "burden of illness" compared to other rheumatic diseases. She also presented an overview of the objectives, activities and accomplishments to date of the Lupus Inspired Advocacy (LUISA) Project www.luisaproject.org
HUMAN GENOME SCIENCES COMPLETES ENROLLMENT IN FIRST OF TWO PHASE 3 LYMPHOSTAT-B® TRIALS - HGS
www.humangenomesciences.com, 22 April 2008 [cached]
"The results of previous studies suggest that belimumab significantly reduced SLE disease activity in serologically active patients," said Professor Sandra V. Navarra, M.D., a principal investigator and head of Rheumatology at the University of Santo Tomas, Manila, Philippines.
GlaxoSmithKline and Human Genome Sciences announce full presentation at ACR of positive phase 3 study results for Benlysta in systemic lupus erythematosus
us.gsk.com, 20 Oct 2009 [cached]
Professor Sandra V. Navarra, M.D., a principal investigator and Head of Rheumatology at the University of Santo Tomas, Manila, The Philippines, presented efficacy and safety results from the Phase 3 BLISS-52 study. "These data suggest that belimumab could emerge to play an important role in the future treatment of patients with SLE," said Dr. Navarra.
Other People with the name "Navarra":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304